Sodium-glucose co-transporter 2 inhibitors: drugs with multiple effects, but which one is relevant to heart failure with preserved ejection fraction? Letter regarding the article 'Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial'.
作者信息
Kokhan Elizaveta, Kiyakbaev Gayrat, Medovchshikov Vadim
机构信息
Sechenov University, Moscow, Russia.
City Clinical Hospital #17, Moscow, Russia.
出版信息
Eur J Heart Fail. 2022 Jul;24(7):1323-1324. doi: 10.1002/ejhf.2466. Epub 2022 Mar 9.
PMID:35238461
Abstract
摘要
Zotero 插件